Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

DR-70 is idle because the global medical community won't prescribe or use it.

The buyout rumor started in April 2011. If the "buyout" is going to solve Radient's capitalization and corporate problems, why is the buyout still just a rumor, 2.5 years later?

If there really is some kind of buyout, the buying Entity lost a LOT of money when the loans went into default and started accruing default/penalty interest. That makes no sense. Money is money and Business is Business, in biotech and everywhere else.

On every message board of every zombie biotech, somebody is trying to keep a Buyout Rumor alive.